We discover and develop novel, high-impact pharmaceutical therapies that help those suffering from disease and chronic conditions. Startups and research institutes develop more than 50% of new drug approvals before they enter clinical trials. However, many high-impact drug therapy candidates never reach the market or clinical trials in traditional academic research settings. Valuable inventions are locked away in academia for a number of reasons, such as insufficient funding, limited internal development resources, and a lack of trusted partnerships in the pharmaceutical industry. Discovery Biotech is uniquely positioned to bridge the academic and pharmaceutical ecosystems. We provide researchers and institutions with a deterministic path from invention to marketable drug therapy.